Niacin/lovastatin

Niacin/lovastatin

Combination of
Niacin	n/a
Lovastatin	Statin
[[{{{component3}}}]]	? Class
[[{{{component4}}}]]	? Class
[[{{{component5}}}]]	? Class
Clinical data
Pregnancy category	US: X (Contraindicated)
Routes of administration	Oral
ATC code	C10BA01 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Niacin/lovastatin (tradename Advicor) is a drug combination used for the treatment of dyslipidemia. It is a combination of niacin and the statin drug lovastatin (best known as Mevacor in the U.S.). The combination preparation is marketed by Abbott Laboratories

It was approved by the FDA on December 17, 2001.

Dosage

The combination is available as tablets containing:.

• 500 mg/20 mg
• 750 mg/20 mg
• 1000 mg/20 mg
• 1000 mg/40 mg

External links

• Advicor website

Template:WikiDoc Sources